320 related articles for article (PubMed ID: 15584991)
21. Reliability and diagnostic use of a test for the search of the hepatitis C virus Ag (AgHCV).
Ravera G; Bottaro LC; Franceschini M; Morando A; De Polo M; Zare M; Giacopelli C; Zanardi S
Hepatogastroenterology; 2006; 53(71):753-6. PubMed ID: 17086882
[TBL] [Abstract][Full Text] [Related]
22. Detection and quantification of functionally defined hematopoietic progenitor cells and tissue specific mRNA within the peripheral blood of myeloma patients after administration of granulocyte colony-stimulating factor and erythropoietin.
Grassinger J; Mueller G; Hart C; Nilsson SK; Haylock DN; Andreesen R; Hennemann B
Eur J Haematol; 2008 Jan; 80(1):20-30. PubMed ID: 18028434
[TBL] [Abstract][Full Text] [Related]
23. Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors.
Kozuka T; Ikeda K; Teshima T; Yoshida C; Shinagawa K; Kojima K; Matsuo K; Bessho A; Sunami K; Hiramatsu Y; Maeda Y; Noguchi T; Yamamoto K; Fujii N; Imai T; Kusumoto KK; Masuda K; Takenaka K; Ishimaru F; Niiya K; Koide N; Tanimoto M; Harada M
Transfusion; 2004 Apr; 44(4):526-32. PubMed ID: 15043568
[TBL] [Abstract][Full Text] [Related]
24. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
25. Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
Sautois B; Baudoux E; Salmon JP; Michaux S; Schaaf-Lafontaine N; Pereira M; Paulus JM; Fillet G; Beguin Y
Haematologica; 2001 Nov; 86(11):1209-18. PubMed ID: 11694408
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
[TBL] [Abstract][Full Text] [Related]
27. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland.
Brojer E; Gronowska A; Medyńska J; Grabarczyk P; Mikulska M; Letowska M; Kryczka W; Gietka A
Transfusion; 2004 Dec; 44(12):1706-10. PubMed ID: 15584984
[TBL] [Abstract][Full Text] [Related]
28. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
[TBL] [Abstract][Full Text] [Related]
29. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
[TBL] [Abstract][Full Text] [Related]
30. [Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction].
Benouda A; Boujdiya Z; Ahid S; Abouqal R; Adnaoui M
Pathol Biol (Paris); 2009 Jul; 57(5):368-72. PubMed ID: 18842351
[TBL] [Abstract][Full Text] [Related]
31. Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors.
Cano H; Candela MJ; Lozano ML; Vicente V
Transfus Med; 2003 Oct; 13(5):259-66. PubMed ID: 14617336
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay.
Tillmann HL; Wiegand J; Glomb I; Jelineck A; Picchio G; Wedemeyer H; Manns MP
Z Gastroenterol; 2005 Jan; 43(1):11-6. PubMed ID: 15650966
[TBL] [Abstract][Full Text] [Related]
33. HCV positivity rate in the seronegative blood donors in China.
Yang Z; Han YX; Jiang JD; Yang Z; Yu YX; Qiu Y
Biomed Pharmacother; 2009 May; 63(4):319-20. PubMed ID: 19246175
[No Abstract] [Full Text] [Related]
34. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
[TBL] [Abstract][Full Text] [Related]
36. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
Nübling CM; Chudy M; Volkers P; Löwer J
Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
[TBL] [Abstract][Full Text] [Related]
37. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
[TBL] [Abstract][Full Text] [Related]
38. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.
Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G
J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076
[TBL] [Abstract][Full Text] [Related]
39. Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells.
Platzbecker U; Bornhäuser M; Zimmer K; Lerche L; Rutt C; Ehninger G; Hölig K
Transfusion; 2005 Jan; 45(1):11-5. PubMed ID: 15647012
[TBL] [Abstract][Full Text] [Related]
40. [Detection of hepatitis C core antigen in intravenous drug addictions].
Cao H; Zhang K; Shu X; Xu QH; Li G
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):304-6. PubMed ID: 22097615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
